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Congenital microphthalmia is a common developmental ocular disorder characterized by shortened axial length.
Isolated microphthalmia is clinically and genetically heterogeneous and may be inherited in an autosomal dominant,
autosomal recessive, or X-linked manner. Here, we studied a five-generation family of Sephardic Jewish origin that
included 38 members, of whom 7 have either unilateral or bilateral microphthalmia of variable severity inherited
as an autosomal dominant trait with incomplete penetrance. After exclusion of several candidate loci, we performed
a genome-scan study and demonstrated linkage to chromosome 15q12-q15. Positive LOD scores were obtained
with a maximum at the D15S1007 locus (maximum LOD score 3.77, at recombination fraction 0.00). Haplotype
analyses supported the location of the disease-causing gene in a 13.8-cM interval between loci D15S1002 and
D15S1040.
Congenital microphthalmia (CMIC [MIM 600165]) is
an ocular malformation characterized by a small eye
attested by shortened axial length (Weiss et al. 1989;
Warburg 1993). The reported prevalence of CMIC at
birth is ∼1.5/10,000 in white populations (Warburg
1993; Bermejo et al. 1998; Busby et al. 1998). Severity
of the disease often ranges from mild to extreme micro-
phthalmia (anophthalmia) within a single family, sug-
gesting variable gene expression (Warburg 1993). Also,
microphthalmia is often asymmetric or unilateral, sug-
gesting that nongenetic factors or somatic genetic events
may also contribute to the phenotype. Some other ocular
abnormalities—namely, cataracts, microcornea, sclero-
cornea, retinal coloboma, and optic-nerve coloboma—
are considered to be part of the spectrum of anomalies
found in isolated CMIC (Warburg 1993). Nonocular
abnormalities are associated with microphthalmia in
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80% of cases. Chromosomal abnormalities of virtually
all chromosomes may result in syndromic microphthal-
mia, trisomy 13 being the most frequently observed.
Moreover, environmental teratogens such as alcohol, ru-
bella, toxoplasma, or cytomegalovirus may also cause
microphthalmia (Warburg 1993).
Although most cases of nonsyndromic microphthal-
mia are sporadic, a few families with autosomal domi-
nant (Pearce 1986; Vingolo et al. 1994; Fryns 1995;
Othman et al. 1998), autosomal recessive (Bateman
1984; Kohn et al. 1988; Gho¨se et al. 1991; Warburg
1993; Zlotogora et al. 1994; Bessant et al. 1998, 1999)
or, more seldom, X-linked recessive inheritance of the
trait (Hoefnagel et al. 1963) have been hitherto reported.
Human eye development begins as early as the fourth
week of gestation and proceeds through the embryonic
and fetal life (for reviews, see Jean et al. 1998; van Hey-
ningen 1998). Many transcription factors and growth
factors are involved in mammalian eye development (for
reviews, see Freund et al. 1996; Graw 1996; Jean et al.
1998). Recently, mutations in the CHX10 homeobox
gene were identified in two families presenting with non-
syndromic microphthalmia (Percin et al. 2000), and mu-
tations in both alleles of the RX gene were identified in
a patient with severe congenital microphthalmia (Vo-
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Figure 1 Pedigree of the family studied and haplotypes obtained using 12 microsatellite DNA markers located on chromosome 15q.
Blackened symbols indicate affected individuals; hatched symbols represent individuals with uncertain status. NS p not studied. The disease-
associated haplotype is boxed.
ronina and Mathers 2000). Two other loci for human
isolated microphthalmia/anophthalmia were previously
identified on chromosome 14q32 (Bessant et al. 1998)
and 11p (Othman et al. 1998).
Here, we report a study of a five-generation family of
Sephardic Jewish origin, including 38 members (fig. 1).
Thirty-five individuals were evaluated by ophthalmo-
logic examination by one of the authors (J.-C.Z.) in most
cases and by general examination by four of the authors
(J.-C.L., A.R.-R., H.P., and P.E.). Inclusion criteria for
microphthalmia was reduction of the total axial length
!20 mm in at least one eye, determined by use of ultra-
sonography (table 1). Seven individuals were considered
to be affected, since they had either unilateral or bilateral
microphthalmia of variable severity. Five affected indi-
viduals had an ocular prosthesis in at least one eye. Two
individuals, IV:10 and V:2, were designed as of uncertain
status, since they had ocular anomalies but normal axial
length of both eyes. The disease trait appears to be in-
herited in an autosomal dominant manner with incom-
plete penetrance and variable expression. For example,
individual IV:10, who carries the mutant allele, has cor-
neal clouding and iridocorneal synechia (Peters’ anomaly
[MIM 604229]) but no microphthalmia, whereas indi-
viduals IV:14 and V:4 have unilateral optic-nerve agen-
esis associated with other ocular abnormalities. This il-
lustrates that virtually any structure of the eye may be
involved in the family described here. Neither associated
extraocular anomaly nor mental retardation was ob-
served, except in affected individual IV:17, who has cleft
lip and palate. Karyotypes performed on blood lym-
phocytes in individuals IV:10 and IV:14 were normal.
Blood sampling was done in each case after informed
consent was obtained by clinicians.
Genomic DNA was extracted from blood leukocytes
using the QIAamp Maxi Kit (Qiagen). We first analyzed
microsatellite DNA markers mapping to seven candidate
loci, using the chemoluminescent detection method (Vig-
nal et al. 1993). We studied linkage to the following
genes: CHX10 (loci D14S63, D14S74, and D14S68),
PAX2 (Sanyanusin et al. 1996; Eccles et al. 1999), PAX6
(Martha et al. 1993; for review, see Prosser and van
Heyningen 1998), MITF (locus D3S3633; for review, see
Jean et al. 1998), andHRY (loci D3S1265 and D3S1314;
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Table 1
Clinical Features of Individuals with Affected or Uncertain Status
Individual Age Sex Status Total Axial Lengtha (mm) Other Ocular Anomalies
IV:8 34 F A RE: 18.0 (microphthalmia) Sclerocornea
LE: 21.0
IV:10b 27 M U RE: 26.5 Iridocorneal synechy, corneal clouding, ptosis, strabismus, myopia
LE: 26.5 Myopia
IV:14 12 F A RE: Prothesis (anophthalmia)
LE: Normal Iris coloboma, optic-nerve agenesis
IV:17 50 M A RE: Normal
LE: Prothesis (microphthalmia)
V:2 12 F U RE: 21.5 Remnant pupillar membranes
LE: 21.5
V:3 15 F A RE: 21.5
LE: Prothesis (microphthalmia)
V:4 13 F A RE: 21.0
LE: 19.0 (microphthalmia) Retinal coloboma, optic-nerve agenesis
V:6 3 F A RE: Microphthalmia Corneal clouding
LE: Prothesis (anophthalmia)
V:7 18 F A RE: Prothesis (anophthalmia)
LE: Prothesis (anophthalmia)
NOTE.—RE p right eye; LE p left eye; A p affected; U p uncertain status.
a Not available for eyes with prothesis and was not determined for patient V:6 (right eye). Microphthalmia is defined by total axial
length (TAL) !20 mm.
b Has normal TAL of both eyes, but has other eye anomalies.
for review, see Freund et al. 1996) and the following
loci: 11p (markers D11S905, D11S4109, D11S4113,
and D11S1314; Othman et al. 1998) and 14q32 (mark-
ers D14S62, D14S65, and D14S78; Bessant et al. 1998).
Next, we performed a genome-scan analysis using
fluorescent microsatellite markers (ABI prism linkage
mapping panels LMSV2). PCR amplifications were per-
formed according to the manufacturer’s recommended
protocols (PE Biosystems). PCR products were denatur-
ated and size-fractionated on a 6% denaturing poly-
acrylamide gel run on an ABI373 sequencer. GENE-
SCAN and GENOTYPER software was used to
determine the size of alleles. Additional fluorescent
markers were analyzed—namely, D15S975, D15S1019,
D15S1040, and D15S118 from the ABI prism linkage
mapping set; HD5; and Ge´ne´thon markers D15S1043,
D15S1031, D15S1010, and D15S144 (Dib et al. 1996).
A two-point LOD-score analysis was computed using
the LINKAGE program of the LINKAGE package ver-
sion 5.2 (Lathrop and Lalouel 1984), under the as-
sumption of an autosomal dominant model with an es-
timated penetrance of 50% and a frequency of the
mutant gene of 1/14,000. Allele frequencies were esti-
mated from family data. For haplotype analysis, we only
considered affected individuals and obligate carriers of
the disease-causing gene, owing to the incomplete pen-
etrance of the disease.
We first excluded the seven analyzed candidate loci.
We found LOD scores consistently !2 at each of these
loci, demonstrating absence of linkage to the disease
gene in the family presented here (data not shown). We
then performed a genome scan study and found a max-
imum LOD score (Zmax) between the disease locus and
microsatellite DNA marker D15S1007 ( atZ p 3.77max
recombination fraction [v] 0; table 2). Additional two-
point LOD scores obtained with 11 other surrounding
markers are shown in table 2. Another marker gave a
positive LOD score 13 at , and two other markersvp 0
gave positive LOD scores 11.9 at .vp 0
Haplotype analysis (fig. 1) showed a telomeric recom-
bination event between markers D15S1007 and
D15S1040 in individual III:1, placing the disease-causing
gene centomeric to the marker D15S1040. Similarly, re-
combination events between loci D15S1002 and
D15S1048 occurred in individuals III:11, IV:8, and IV:
17, indicating that the disease gene is telomeric to locus
D15S1002. Thus, in this family, the disease gene lies
within a 13.8-cM region on chromosome 15q12-q15,
bounded proximally by locus D15S1002 and distally by
locus D15S1040. Moreover, two recombinations oc-
curred in affected individual V:3, on the disease-asso-
ciated chromosome inherited from individual IV:6 (fig.
1)—the first one between loci D15S1002 and D15S1048
and the second one between loci D15S1043 and
D15S1031. This result allows the exclusion of a 2.2-cM
region, flanked by loci D15S1048 and D15S1043 and
located within the 13.8-cM candidate interval. Thus,
two genetic intervals—encompassing, respectively, 4.5
cM between loci D15S1002 and D15S1048 and 7.1 cM
between loci D15S1043 and D15S1040—are likely to
contain the disease-causing gene. To date, we have not
been able, by using other microsatellite DNA mark-
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Table 2
Two-Point LOD Scores between Microphthalmia and 12
Chromosome 15q Microsatellite DNA Markers
MARKER
LOD SCORE AT v p
0 .01 .05 .1 .2 .3 .4
D15S975 1.394 .641 .438 .827 .865 .605 .256
D15S1002 7.790 .939 .842 1.357 1.441 1.090 .557
D15S1048 .338 2.501 2.877 2.762 2.179 1.409 .579
D15S1019 .443 2.542 2.902 2.770 2.162 1.388 .590
D15S165 .411 2.574 2.951 2.837 2.256 1.483 .639
D15S1043 1.514 .003 .544 .657 .586 .401 .189
D15S1031 2.936 2.869 2.598 2.252 1.554 .891 .351
D15S1010 1.906 1.866 1.706 1.503 1.093 .693 .324
D15S144 3.743 3.669 3.370 2.984 2.173 1.339 .576
D15S1007 3.771 3.699 3.404 3.022 2.214 1.364 .565
D15S1040 .188 1.581 1.997 1.947 1.526 .978 .439
D15S118 1.256 1.023 .163 .143 .257 .230 .149
ers (not shown), to exclude the entire D15S1002–
D15S1048 interval on the basis of haplotype analysis.
The present study strongly suggests the assignment of
a nonsyndromic autosomal dominant microphthalmia
gene to chromosomal region 15q12-q15 within a 13.8-
cM interval bounded by loci D15S1002 and D15S1040.
On the basis of haplotype analysis, a 2.2-cM region de-
fined by loci D15S1048 and D15S1043 and located
within the 13.8-cM critical interval was excluded. In-
deed, we observed a double recombination in patient
V:3 within a 6.8-cM interval defined by loci D15S1002
and D15S1031. The probability of such an event is very
low, ∼0.5%. However, it is worth noting that both re-
combination events occurred close to potential hotspots
for recombinations (Amos-Landgraf et al. 1999; Chris-
tian et al. 1999).
Clinical expression of the disease was extremely var-
iable in individuals carrying the disease-associated hap-
lotype. For example, patients IV:8 and V:4 had unilateral
microphthalmia, and patient V:7 had bilateral ano-
phthalmia. Such an intrafamilial variable expression of
the disease has been described elsewhere in families with
microphthalmia (Warburg 1993; Zlotogora et al. 1994;
Fryns 1995; Bessant et al. 1999). More surprisingly, pa-
tient IV:10 had no microphthalmia but did have Peters’
anomaly, including corneal clouding, iridocorneal sy-
nechy, and ptosis, whereas patient IV:14 had unilateral
anophthalmia and controlateral isolated optic-nerve
agenesis, with a normal ocular globe. The latter obser-
vation suggests that anterior segment dysgenesis may be
allelic to posterior segment anomalies, at least in the
family reported here. Incidentally, individual V:2, who
inherited part of the disease-associated haplotype, had
remnant pupillar membranes, a feature that may be en-
countered in normal eyes. It is striking that each of the
five carriers of the disease-causing gene in generation III
has normal eyes, whereas only 2/6 carriers in generation
IV are considered to be unaffected, and 0/4 patients with
the entire disease-associated haplotype in generation V
are unaffected. The apparently increasing penetrance of
the disease trait through successive generations may sug-
gest anticipation, a feature usually associated with tri-
nucleotide-repeat expansion. Alternatively, considering
the small number of individuals studied, we cannot ex-
clude that this observation may be fortuitous. The phe-
nomenon of anticipation has been proposed previously,
to explain a similar observation of increased penetrance
in subsequent generations in a family with iris coloboma
(Barros-Nunez et al. 1995).
More than forty transcription factors are expressed
during mammalian eye development (Freund et al. 1996;
Jean et al. 1998). To our knowledge, none of these genes
have been mapped to the candidate interval defined
by loci D15S1002 and D15S1040 (Genome Database).
Since the homozygous knockout of the Hairy Enhancer
of Split homologue 1 (HES1) gene in mouse leads to
abnormal eye development (Tomita et al. 1996), the
TLE3 gene, which belongs to a family of corepressors
coacting with HES proteins, should be considered as a
candidate gene. However, the precise genetic location of
the TLE3 gene with respect to our candidate interval
remains to be determined (Richard et al. 1994; Liu et
al. 1996). At least six expressed-sequenced tags (ESTs),
previously obtained from retinal tissues, map within the
D15S1002-D15S1040 candidate interval (GeneMap’99
database). One of these ESTs, stSG29857, is expressed
in fetal retina and may contain cDNA sequence of a
candidate gene.
It is interesting to note that severe syndromic bilateral
microphthalmia was associated with an apparently bal-
anced de novo reciprocal translocation 46, XY, t(1;15)
(q41;q21.2), suggesting that either the 1q41 or 15q21.2
regions may contain a gene that is important for eye
morphogenesis (Smith et al. 1994). On the other hand,
interstitial deletions of chromosome 15q13-q15 (Autio
et al. 1988), 15q12-q14 (Tonk et al. 1995), and 15q21.2-
q22.1 (Martin et al. 1990) were not associated with eye
malformation, suggesting that this disorder is not the
result of haploinsufficiency of a gene in this region.
Since a large number of genes appear to be involved
in vertebrate eye development, the linkage analysis pre-
sented here in a large family with autosomal dominant
isolated microphthalmia provides an opportunity to fo-
cus on a specific area of the genome, namely the prox-
imal long arm of chromosome 15. Efforts are being un-
dertaken with the aim of identifying the disease gene
itself.
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